dc.contributor.author | Al-Subeihi, Mawada Salem | |
dc.date.accessioned | 2019-02-27T09:16:22Z | |
dc.date.available | 2019-02-27T09:16:22Z | |
dc.date.issued | 2018-05-04 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/546 | |
dc.description | Human immunodeficiency virus (HIV) is the virus that causes acquired
immunodeficiency syndrome (AIDS),when HIV enters the bloodstream by way of body
fluids, the virus invades and kills CD4 cells. CD4 cells are key cells of the immune
system. When these cells are destroyed, the body is less able to fight disease. AIDS
occurs when the number of CD4 cells decreases below a certain level and the person
gets sick with diseases that the immune system would normally fight off.[2] HIV
continues to be a major global public health issue. In 2016, an estimated 36.7 million
people were living with HIV (including 1.8 million children) – with a global HIV
prevalence of 0.8% among adults.1 2 Around 30% of these same people do not know
that they have the virus.HIV can be transmitted through the body fluid (blood, semen,
rectal fluids, vaginal fluids, and breast milk), so it can transmitted from the mother to
the fetus which called perinatal transmission.
[2]it happened:1. During pregnancy, HIV
can pass through the placenta and infect the fetus.2.During labor and delivery, the baby
may be exposed to the virus in the mother’s blood and other fluids. Once this occurs,
the risk of transmitting HIV to the baby increases. Most babies who get HIV from their
mothers become infected around the time of delivery.3.Breastfeeding also can transmit
the virus to the baby | en_US |
dc.description.abstract | Progress towards achievement of global targets for the prevention of mother-to-child
transmission of HIV (PMTCT) and paediatric HIV care and treatment is an integral part
of global and national HIV and AIDS responses. This report documents the
development of the global and national monitoring and reporting systems for PMTCT
and paediatric HIV care and treatment programmes, achievements and remaining
challenges. A review of the development of the monitoring and reporting process since
2011–2016 was conducted using existing published literature and taking into account
changes in WHO HIV treatment guidelines, global HIV goals and targets,
programmatic and methodological developments, and increased need for interagency
partnerships, coordination and harmonization of global monitoring and reporting
mechanisms. | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Prevention of HIV transmission to the fetus | en_US |
dc.type | Other | en_US |